Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Antibiotic therapy for culture-proven bacterial overgrowth in children with intestinal failure results in improved symptoms and growth.

< BACK TO ARCHIVE


2022 Jun 01


J Pediatr Gastroenterol Nutr


http://www.ncbi.nlm.nih.gov/pubmed/35653418?dopt=Abstract

Antibiotic therapy for culture-proven bacterial overgrowth in children with intestinal failure results in improved symptoms and growth.

Authors

Antibiotic therapy for culture-proven bacterial overgrowth in children with intestinal failure results in improved symptoms and growth.
Culbreath K, Knell J, Keefe G, Han SM, Hong CR, Riley HB, Liu E, McAdam AJ, Modi BP, Jaksic T, Duggan CP, Carey AN
J Pediatr Gastroenterol Nutr. 2022 Jun 01.
PMID: 35653418.

Abstract

To evaluate symptoms, enteral tolerance, growth, and antibiotic regimens in pediatric intestinal failure (IF) patients after treated with antibiotic therapy for small bowel bacterial overgrowth (SBBO).
Read This Paper